Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Bupropion/zonisamide

Next Previous
X
Search
Drug Profile

Bupropion/zonisamide

Alternative Names: Bupropion SR/zonisamide IR; Bupropion SR/zonisamide SR; Empatic™; Excalia™; Zonisamide IR/bupropion SR; Zonisamide SR/bupropion SR; Zonisamide/bupropion

Latest Information Update: 01 Sep 2015

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Orexigen Therapeutics
  • Class Antidepressants; Antiepileptic drugs; Isoxazoles; Obesity therapies; Propiophenones; Sulfonamides
  • Mechanism of Action Adrenergic uptake inhibitors; Antioxidants; Calcium channel antagonists; Dopamine release stimulants; Dopamine uptake inhibitors; Neuron inhibitors; Serotonin release stimulants; Sodium channel antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • Discontinued Obesity

Most Recent Events

  • 20 Mar 2013 Bupropion/Zonisamide is available for licensing as of 20 Mar 2013. www.orexigen.com
  • 30 Sep 2009 Efficacy and adverse events data from a phase IIb trial in obesity released by Orexigen Therapeutics
  • 09 Oct 2008 Data from two post-hoc analyses from a phase IIb trial in Obesity presented at the 2008 Obesity Society Annual Scientific Meeting

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top